Acute Monoblastic and Monocytic Leukemia

Acute Monoblastic and Monocytic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

86 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 9
Recruiting: 6
Ph III recruiting: 0
Growth YoY: —
Industry share: 11%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (19)

clinicaltrialsPublishedShowing 51–58 of 58 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00095797	XK469R in Treating Patients With Refractory Hematologic Cancer	completed	Phase 1	60	National Cancer Institute (NCI)NIH	1	Feb 8, 2013	clinicaltrials
NCT00101296	Tipifarnib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia	completed	Phase 1	30	National Cancer Institute (NCI)NIH	1	Feb 4, 2013	clinicaltrials